PharmaBoardroom

Biosimilars & Biologics: Chile

The key facts about biosimilars and biologics in Chile. Prepared in association with Carey, a leading global law firm, this is an extract from The…

Orphan Drugs & Rare Diseases: Chile

Want to know more about orphan drugs and rare diseases in Chile? Read on! Prepared in association with Carey, a leading global law firm, this is an…

Christopher Posner – EVP of Region US, LEO Pharma A/S;…

Christopher Posner, US head for Danish medical dermatology specialist LEO Pharma, outlines how a mid-sized European company navigates the US market's…

Korean Celltrion Makes First Big Global Move with Acquisition of…

Korean biosimilar firm Celltrion's USD 266 million acquisition of Japanese outfit Takeda assets in the Asia-Pacific region marks a significant moment…

Singapore Pharma Exports Rise as Global API Demand Surges

The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global crisis, the island city-state is…

US Generics: Company Culture Key to Attracting Talent

Two leading executives in the US generics market outline why robust company culture is key to attracting top talent that might otherwise gravitate…

Veronique Walsh – General Manager, Bristol Myers Squibb…

Veronique Walsh, General Manager of Bristol Myers Squibb (BMS) – Benelux, explains her ambition to build a new company culture following the…

Top 5 RNA-Based Biopharma Companies

Below we present a list of the top 5 public biopharma companies that focus on developing RNA-based therapies. RNA interference (RNAi) is a natural…

South Africa Pharma News Roundup June 2020

Below is a roundup of latest news from South Africa's life sciences and healthcare industries, including a call to overhaul patent laws to allow…

SCM Lifescience: A Global Approach to Korean Regenerative…

Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in several global M&A deals in…

CanSinoBIO: China’s Leading COVID-19 Vaccine Developer…

Chinese biotech CanSinoBIO is racing against the clock to have a COVID-19 vaccine ready to begin production in early 2021. The firm’s senior VP of…

Alex Wong – CEO, Xcelom

Alex Wong, CEO of Xcelom sat down with PharmaBoardroom to discuss the company’s non-invasive prenatal testing (NIPT) technology and increasing…

Tagged with M